School of Pharmacy

Journal Articles

• Richarson A, Bracegirdle L, McLachlan SIH, Chapman SR. 2013. Use of a Three-Dimensional Virtual Environment to Teach Drug-Receptor Interactions. American Journal of Pharmaceutical Education, vol. 77(1), Article 11. doi> link>
• Thompson J and Chapman SR. 2012. Evaluation of a Computerised Decision Support System for Use by Non Medical Prescribers in Type 11 Diabetes. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 21, 298. link>
• Latter S, Smith A, Blenkinsopp A, Nicholls P, Little P, Chapman S. 2012. Are nurse and pharmacist independent prescribers making clinically appropriate prescribing decisions? An analysis of consultations. JOURNAL OF HEALTH SERVICES RESEARCH & POLICY, vol. 17(3), 149-156. link> doi>
• Chapman SRC, Naughton B, Thayer N. 2010. Seroquel advertising-the good the bad and the atypical. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 19(6), 647-648. link>
• Bracegirdle L and Chapman SR. 2010. Programmable Patients: Simulation of Consultation Skills in a Virtual Environment. Bio-Algorithms and Med-Systems, vol. 6(No. 11), 111-115.
• Chapman SR and Bracegirdle L. Simulation and consultation skills for virtual environment. Bio-algorithms & Med-Systems, vol. 6, 111-115.
• Clyne W and Chapman S. 2008. Achieving concordance through use of decision-support tools. Prescriber, vol. 19(8), 41-44. doi>
• Chapman SR. 2008. Making decisions about prescribing in diabetes. Practice Nursing, vol. 19, 128-131.
• Heatlie HF, Woodvine P, Bashford J, Savage T, Chapman SR. 2007. Trends in primary care prescribing for patients with heart failure. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 16, S84-S85. link>
• Woodvine PS, Pate R, Chapman SR. 2007. Using IMS hospital drug issue data to enable secondary care prescribers to assist primary care organisations with their objectives and targets. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 16, S100. link>
• Woodvine PS and Chapman SR. 2007. Using structured audits to increase the percentage of patients achieving an agreed lipid lowering target. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 16, S236. link> doi>
• Heatlie H, Woodvine P, Bashford J, Chapman S. 2007. Trends in primary care prescribing for patients with heart failure. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 16(5), 590. link>
• Woodvine P, Pate R, Chapman S. 2007. Using Intercontinental Medical Statistics hospital drug issue data to enable secondary care prescribers to assist Primary Care Trusts with their objectives and targets. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 16(5), 594. link>
• Chapman SR. 2007. Developing a decision support tool for nurse prescribers. Nursing Times, vol. 103(36), 29-31.
• Chapman S. 2007. Outcome guarantees: putting your money where your mouth is. Prescriber, vol. 18(17), 11-13.
• Chapman S. 2007. Outcome guarantees: putting your money where your mouth is. (Editorial). Prescriber, vol. 18, 11-13.
• Chapman SR. 2007. The importance of good prescribing support when determining patients' risk and benefit cannot be underestimated. Pharmacy in Practice, vol. 17, 219-222.
• Heatlie HF, Chapman S, Woodvine P, Savage T. 2006. Assisting primary care trusts with their analysis of QOF indicators in relation to prescribing. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 15(4), 285. link>
• Chapman S. 2005. Analysis of a new service development: educational out-reach support. Pharmacoepidemiology and Drug Safety, S2.
• Allinson M, Chapman S, Sawyer J. 2005. Ceating a novel medicines management support service. Pharmacoepidemiology and Drug Safety, S2.
• CHAPMAN S. 2004. ORCA: a new tool for the review of medication in asthma management. Nurse Prescribing.
• CHAPMAN S, REEVE E, PRICE D, RAJARATNAM G, NEARY R. 2004. Outcomes guarantee for lipid-lowering drugs: results from a novel approach to risk sharing in primary care. BRITISH JOURNAL OF CARDIOLOGY.
• CHAPMAN S. 2004. Tips for seeing medical representatives. Supplementary prescribing in practice.
• Chapman S. 2003. Pharma focus. Puff adders. Health Serv J, vol. 113(5883), suppl 6-7. link>
• Chapman S. 2003. Puff Adders. Health Services Journal, vol. 113(5883), 6-7.
• CHAPMAN S, REEVE E, RAJARATNAM G, NEARY R. 2003. Setting up an outcomes guarantee for pharmaceuticals: New approach to risk sharing in primary care. British Medical Journal. doi>
• CHAPMAN S. 2003. The Development of Drug Utilisation Research in Europe. European Journal of Pharmaceutical Sciences.
• Ashcroft D, Frischer M, Lockett J, Chapman S. 2002. Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study. Pharmacoepidemiology and Drug Safety. doi>
• Chapman S and Heatlie H. 2002. Morbidity mapping: a technique to help link needs and services in primary care. Medicines Management.
• Chapman S. 2002. Strategies for best prescribing where no national service frameworks exist. Pharmaceutical Journal.
• Ashcroft DM, Chapman SR, Clark WK, Millson DS. 2001. Upper gastroduodenal ulceration in arthritis patients treated with celecoxib. Ann Pharmacother, vol. 35(7-8), 829-834. link>
• Shelley M, Croft P, Chapman S, Pantin C. 2001. Is the quality of asthma prescribing, as measured by the general practice ratio of cortiocosteroid to bronchodilator, associated with asthma morbidity?. Journal of Clinical Epidemiology.
• Chapman S. 2001. Managing medicines: drugs for asthma. Practice Nurse.
• Chapman S. 2001. Managing medicines: dyspepsia. Practice Nursing.
• Chapman SR. 2001. Prescribing informtion services: making sense of primary care data. Journal of Clinical Pharmacology and Therapeutics. doi>
• Ashcroft DM, Chapman SR, Lockett J. 2001. Supporting the implemention of prescribing advice in PCOs. The Pharmaceutical Journal.
• Frischer M, Norwood J, Bashford J, Millson D, Chapman S. 2001. Trends in antibiotic prescribing and associated indications in primary care from 1993-1997. Journal of Public Health Medicine. doi>
• Shelley M, Croft P, Chapman S, Pantin C. 2000. Is the quality of asthma prescribing, as measured by the general practice ratio of corticosteroid to bronchodilator, associated with asthma morbidity?. J Clin Epidemiol, vol. 53(12), 1217-1221. link> doi>
• Frischer M, Norwood J, Heatlie H, Millson D, Lowdell J, Hickman M, Chapman S, Bashford J. 2000. A comparison of trends in problematic drug misuse from two reporting systems. J Public Health Med, vol. 22(3), 362-367. link> doi>
• Thompson V, Boardman H, Chapman S, Crome P. 2000. A randomised controlled trial of education outreach to improve psychotropic drug prescribing in nursing homes. Age and Ageing, vol. 29(2), 61.
• Frischer M, Heatlie HF, Chapman S, Millson DS. 2000. Defining the spectrum of appropriate prescribing: implications for effective medicines management. International Journal of Pharmaceutical Medicine, vol. 14, 17-21.
• Frischer M, Heatlie HF, Chapman S, Bashford J, Norwood J. 2000. Prescribing of inhalers in airways disease: An analysis of age-specific rates and switching between delivery systems. Journal of Applied Therapeutic Research, vol. 2, 253-259.
• Frischer M, Heatlie H, Chapman S, Bashford J, Norwood J, Millson D. 2000. Ratio of inhaled corticosteroid to bronchodilator treatment and asthma hospitalisation. Curr Med Res Opin, vol. 16(1), 8-13. link>
• Frischer M, Heatlie HF, Chapman S, Bashford J, Norwood J, Millson DS. 2000. Ratio of inhaled corticosteroid to broncholilator and hospital referral for asthma. Drugs: Education, Prevention and Policy, vol. 16(1), 8-13.
• Chapman S. 2000. Report on the 1999 Meeting of the UK Drug Utilization Research Group, Friday 18 June 1999, Keele Hall, University of Keele. Pharmacoepidemiol Drug Saf, vol. 9(1), 65-70. link> doi>
• Chapman S. 2000. The new pharmacy plan: how should the profession respond?. 265, 618.
• Chapman S, Heatlie HF, Frischer M, Bashford J. 2000. Using the General Practice Research Database to generate and "at risk register" for a primary care stroke prevention programe. Value in Health, vol. 3(5).
• Frischer M, Heatlie H, Chapman S, Norwood J, Bashford J, Millson D. 1999. Should the corticosteroid to bronchodilator ratio be promoted as a quality prescribing marker?. Public Health, vol. 113(5), 247-250. link> doi>
• Short D and Chapman S. 1999. Managing the transition to CFC-free metered dose inhalers. Pharmaceutical Journal, vol. 262, 198-199.
• Abell S, Chapman S, Nadin L, Warren R. 1999. Seasonal variation in flouroquinolone prescribing. Antimicrobial Chemotherapy, vol. 43, 315-316. doi>
• Chapman S, Boardman H, Thompson V. 1999. Educational outreach in nursing homes. Pharmacoepidemiology and Drug Safety, vol. 8, S86.
• Heatlie HF and Chapman S. 1999. Explaining variation in practice prescribing of hormone replacement therapy in the UK: A study using a geographic information system. Pharmacoepidemiology and Drug Safety, vol. 4, 1.
• Chapman S. 1999. Placing prescribing in context. Pharmaceutical Times, 16-18.
• Frischer M, Heatlie HF, Chapman S, Bashford J, Norwood J. 1999. Switching between metered dose inhalers (MDIs) and dry powder inhalers (DPIs) in airways disease: an analysis of age-specific rates using the General Practice Research Database. Journal of Applied Therapeutic Research, vol. 2, 253-259.
• Boardman H, Thompson V, Chapman S. 1999. Views of general practitioners and nursing home staff about an educational outreach programme. Pharmaceutical Journal (Suppl: Pharmacy Practice Research), vol. 263, R44.
• Millson D and Chapman S. 1998. Medicines management. NICE (National Institute for Clinical Excellence) but not easy. Health Serv J, vol. 108(5625), 35. link>
• Bashford JN, Norwood J, Chapman SR. 1998. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. BMJ, vol. 317(7156), 452-456. link>
• Frischer M, Chapman S, Bashford J, Norwood J, Heatlie HF. 1998. General practice research database for prescribing analysis. Lancet, vol. 351, 453-454. doi>
• Millson DS and Chapman S. 1998. NICE but not easy: are the pharmaceutical industry and health service ready for the cost and risk implications of NICE. Health Services Journal, vol. 109(5625), 35.
• White DJ, Billingham C, Chapman S, Drake S, Jayaweera D, Jones S, Opaneye A. 1997. Podophyllin 0 center dot 5% or 2 center dot 0% v podophyllotoxin 0 center dot 5% for the self treatment of penile warts: A double blind randomised study. GENITOURINARY MEDICINE, vol. 73(3), 184-187. link>
• Shelley M, Croft P, Pantin C, Chapman S. 1997. Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing - Reply. BRITISH MEDICAL JOURNAL, vol. 314(7081), 682. link>
• Avorn J, May F, Chapman S. 1997. Interventions to improve prescribing through educational outreach; a global overview of "academic detailing" programmes. Pharmacoepidemiology and Drug Safety, vol. 6, S66.
• White DJ, Billington C, Chapman S. 1997. Podophyllin 0.5% v podophyllotoxin 0.5% for the self-treatment of penile warts: a double blind randomised study. Genitourinary Medicine, vol. 73, 184-187.
• Pryce AJ, Heatlie HF, Chapman SR. 1996. Buccaling under the pressure: influence of secondary care establishments on the prescribing of glyceryl trinitrate buccal tablets in primary care. BMJ, vol. 313(7072), 1621-1624. link>
• Shelley M, Croft P, Chapman S, Pantin C. 1996. Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? Cross sectional study linking prescribing data to data on admissions. BMJ, vol. 313(7065), 1124-1126. link>
• Gough A, Chapman S, Wagstaff K, Emery P, Elias E. 1996. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ, vol. 312, 169.
• Pryce A, Heatlie HF, Chapman S. 1996. Buccaling under the pressure: influences of secondary care establishments on the prescribing of glyceryl trinitrate buccal tablets in primary care. BMJ, vol. 313, 1262-1264.
• Shelley M, Croft P, Chapman S, Pantin C. 1996. Is the ratio of inhaled corticosteroid broncholilator a good indicator of the quality of asthma prescribing?. BMJ, vol. 313, 1124-1126.
• Chapman S. 1996. Managing medicines - non-steroidal anti-inflammatory drugs. Practice Nursing, vol. 7(18), 37-41.
• Chapman S. 1996. Medicines and their management: antibiotics. Practice Nursing, vol. 7(19), 38-42.
• Chapman S and Heatlie HF. 1995. Are proton pump inhibitors being used appropriately?. Pharmacoepidemiology and Drug Safety, vol. 1, 545.
• Chapman S. 1995. Choosing an appropriate asthma delivery system. Community Nurse (Nurse Prescriber), vol. 10, 33-34.
• Chapman S. 1995. Choosing asthma drugs. Community Nurse (Nurse Prescriber), vol. 1(3), 5-7.
• Chapman S, Avorn J, May T. 1995. Providing independent advice to prescribers: a multi-national presentation on "academic detailing". Pharmacoepidemiology and Drug Safety, vol. 1, 545.
• Shelley M, Chapman S, Pantin C, Croft P. 1995. The relationship between the ratio of inhaled corticosteroid to inhaled broncholilator and asthma admission in North Staffordshire. Pharmacoepidemiology and Drug Safety, vol. 1, 545.
• Chapman S, Shelley M, Pantin C. 1994. A comparison of prescribing indicators for asthma controlled for referral data and deprivation indices. Pharmacoepidemiology and Drug Safety, 569.
• Chapman S. 1994. A view using prescribing analysis and cost trends data. Cardiology, vol. 85(Suppl 1), 46-53. doi>
• Chapman S. 1994. Drug formularies--good or evil? A view using prescribing analyses and cost trends data. Cardiology, vol. 85 Suppl 1, 46-53. link>
• Chapman S. 1994. Screening for microalbuminuria in the elderly; should this be done in primary care?. ??????, 513-515.
• Chapman S, Billington C, Nadin L. 1994. The relationship between prescribing of oral contraceptives; 'The PC4 Morning After Pill' and social deprivation in the West Midlands. Pharmacoepidemiology and Drug Safety, 568.
• Chapman S, Newton JM, Rowe R. 1988. Characterisation of the sphericity of particles by their one plan critical stability. Journal of Pharmaceutical Pharmacology, vol. 40, 503-505.
• Chapman S, Newton JM, Woodhead P. 1983. Vibratory consolidation of particle size fractions of powers. Journal of Pharmaceutical Pharmacology, vol. 35, 621-626.
• Chapman S. 1980. Dissolution rates of propantheline bromide tablets BP. Journal of Pharmaceutical Pharmacology (supplement), vol. 32, 20.

Chapters

• McDonald R, Chapman S, Bottomley J. 2004. Disease management and the technique of programme budgeting and marginal analysis. In Pharmacoeconomics. Walley T, Haycox AR, Boland A, Breckenridge AM (Eds.). Churchill Livingstone.
• McDONALD R and CHAPMAN S BOTTOMLEY J. 2004. Disease management and the techniques of programme budgeting and marginal analysis. In Pharmacoeconomics. Walley T, Haycox A, Boland A (Eds.). Churchill Livingstone, London.
• GRANBY T and CHAPMAN S. 2004. Evidence-based prescribing. In Independent and Supplementary Prescribing. Courtenay M and Griffiths M (Eds.). University Press, Cambridge.
• CHAPMAN S, DURIEUX P, WALLEY T. 2004. Good prescribing practice. In Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Mossialos E, Mrazek M, Walley T (Eds.). Open University Press, Maidenhead.
• Chapman S. 2003. Experiences with Professional Education. In Drugs and Money. Dukes MNG, Haaijer-Ruskamp FM, de Joncheere CP, Rietveld AH (Eds.). (Seventh ed.). Netherlands: IOS Press.
• Chapman S. 2002. Experiences with professional education. In Drugs and Money. al DJKE (Ed.). IOS Press, Netherlands.
• Chapman S. 1999. Nurse prescribing. Can nurses manage it?. Jones M (Ed.).
• Earl-Slater A and Norwood J. 1998. Economic and public health aspects of drugs usage. In Medicines Management. Panton RS and Chapman S (Eds.). BMJ Publishing Group.
• Chapman S. 1998. Educational Outreach. In Medicines Management. Panton RS and Chapman S (Eds.). London: BMJ Books and Pharmaceutical Press.
• Clark W and Mucklow JC. 1998. Gathering and weighing the evidence. In Medicines Management. Panton RS and Chapman S (Eds.). London: BMJ Books.
• Blenkinsopp A, Clark W, Purves I, Fisher M. 1998. Getting research into practice. In Medicines Management. Panton RS and Chapman S (Eds.). BMJ Publishing.
• Frischer M and Chapman S. 1998. Issues and directions in prescribing analysis. In Medicines Managemengt. Panton RS and Chapman S (Eds.). London: BMJ Books.
• Fitzpatrick RW and Coker N. 1998. Systems for controlling prescribing in medicines management. In Medicines Management. Panton RS and Chapman S (Eds.). London: BMJ Books.

Other

• Savage TJ, Pearce HL, Lockett J, Chapman SR. 2010. Health information for commissioners: asthma & chronic obstructive pulmonary disease (COPD). PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (vol. 19, pp. 656-657). link>
• Chapman S. 2007. Developing decision support systems for nurse prescribers.
• Chapman S. 2007. Prescribing decision support for diabetes in primary care.
• Chapman S. 2007. The Pharmaceutical Price Regulation Scheme.
• Heatlie HF, Woodvine P, Bashford J, Chapman S. 2007. Trends in primary care prescribing for patients with heart failure. (Abstract).
• Woodvine P, Pate R, Chapman S. 2007. Using IMS hospital drug issue date to enable secondary care prescribers to assist primary care trusts with their objectives and targets. (Abstract).
• Heatlie HF, Chapman S, Woodvine P, Savage T. 2006. Assisting primary care trusts with their analysis of QoF indicators in relation to prescribing. (Abstract).
• Heatlie HF, Chapman S, Sawyer J, Bashford J. 2005. A comparison between the use of Cox IIs and other NSAIDs using the GPRD. Wiley InterScience.
• Heatlie HF, Chapman S, Savage T, Bashford J. 2005. A comparison between the use of COX IIs and other NSAIDs using the GPRD.
• Chapman S. 2005. Practitioner, ethical and managerial issues. In GA. Baker (Ed.). London: Royal Society of Medicines Press Ltd.
• Chapman S. 2003. The development of drug utilisation research in the UK & Europe. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (vol. 19, p. S14). link>
• Chapman S and Reeve E. 2003. Outcomes Guarantee - a new initiative to reduce drug wastage in primary care. International Journal of Pharmacy Practice.
• Chapman S and Reeve E. 2003. Risk sharing in a state funded health service: Outcomes Guarantee Project. doi>
• Chapman S and Reeve E. 2003. Sharing the risk of promoting an NSF: the Outcomes Guarantee Project.
• Chapman S and Reeve E. 2003. Risk sharing in a state health service: Outcomes Guarantee Project. doi>
• Chapman S and Dwyer K. 2002. An evaluation of the relative efficacy of a pressured metered dose inhaler and a breath actuated device. Pharmacoepidemiology and Drug Safety.
• Heatlie H and Chapman S. 2002. Making the link between healthcare need and service provision: Mapping English Primary Care Organisations (PCOs) morbidity and prescribing. Pharmacoepidemiology and Drug Safety.
• Gogna N, Short D, Chapman S. 2000. Atypical Anti-psychotic Medication Regional Meeting Report.
• Short D, Chapman S, Frischer M. 1999. How should the transition to CFC-free inhalers be managed?.
• Black P, Chapman S, Short D. 1999. The transition to CFC-free inhalers Conference Report.
• Black P, Chapman S, Short D. 1999. UK Drug Utilisation Research Group Regional Meeting Report.
• Chapman S. 1997. Educational outreach using community pharmacists to deliver prescribing messages to general practitioners: the IMPACT project.
• Chapman S, Heatlie HF, Mucklow JC. 1994. Prescribing in gastroenterology - has fundholding produced change?. RPS.
• Chapman S. 1993. A national sepsis database for HA-IA human monoclonal antibody. Oxford: Oxford University.
• Chapman S. 1992. Using PACT data to evaluate the cost of community pharmacy screening for microalbuminuria in diabetics.
• Chapman S. 1986. The influence of process variables on the shape of spherical granules.